Oral Transmucosal Drugs Market: By Product Type (Tablets, Films, Liquid & Spray, and Others), By Route of Administration (Sublingual Mucosa, Buccal Mucosa, and Others), By Indication (Opioid Dependence, Nausea and Vomiting, Erectile Dysfunction, Neurological Disorders, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) And Region - Global Analysis of Market Size, Share & Trends For 2021-2022 And Forecasts To 2032
Oral Transmucosal Drugs Market: By Product Type (Tablets, Films, Liquid & Spray, and Others), By Route of Administration (Sublingual Mucosa, Buccal Mucosa, and Others), By Indication (Opioid Dependence, Nausea and Vomiting, Erectile Dysfunction, Neurological Disorders, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) And Region - Global Analysis of Market Size, Share & Trends For 2021-2022 And Forecasts T%li%%li%2032
PRODUCT OVERVIEW
The Global Oral Transmucosal Drugs Market was valued at 28.65 billion USD in 2021 and is expected t%li%%li%reach 58.2 billion USD by 2032, increasing at a CAGR of 6.7% during the forecast period, i.e., 2022-2032
Oral transmucosal delivery means systemic administration of medication via the mucous membrane of the oral cavity. The transmucosal drug delivery system has various benefits making it profitable market. Transmucosal drug delivery permits drugs t%li%%li%bypass the body's natural defence mechanisms and are available in dosage forms like tablets, gels, thin films and they dissolve in the mouth. Oral transmucosal drugs can bypass hepatic first-pass metabolism and avoid degradation of drugs in the gastrointestinal tract.
MARKET HIGHLIGHTS
The Global Oral Transmucosal Drugs Market was valued at 28.65 billion USD in 2021 and is expected t%li%%li%reach 58.2 billion USD by 2032, increasing at a CAGR of 6.7% during the forecast period, i.e., 2022-2032 owing t%li%%li%increasing incidence of respiratory problems, autoimmune disorders, cancer, mucositis etc. The people getting affected by autoimmune disorders, respiratory problems, oral cancer, etc. are increasing leading t%li%%li%rise of the market across the world. This increases the requirement of oral transmucosal drugs t%li%%li%prevent gastrointestinal degradation and provide rapid onset of action. The number of patients with chronic diseases is rising across the world which increases the pre-surgical procedures which is expected t%li%%li%boost the global oral transmucosal drugs market.
Global Oral Transmucosal Drugs Market Segments
Growth Drivers
Incidence of chronic diseases may boost the market growth
Rising R&D activities may drive the market growth
Restraint
High Cost may restrain the market growth
Key Players
Global Laboratory Temperature Control Units Market is further segmented by region into:
PRODUCT OVERVIEW
The Global Oral Transmucosal Drugs Market was valued at 28.65 billion USD in 2021 and is expected t%li%%li%reach 58.2 billion USD by 2032, increasing at a CAGR of 6.7% during the forecast period, i.e., 2022-2032
Oral transmucosal delivery means systemic administration of medication via the mucous membrane of the oral cavity. The transmucosal drug delivery system has various benefits making it profitable market. Transmucosal drug delivery permits drugs t%li%%li%bypass the body's natural defence mechanisms and are available in dosage forms like tablets, gels, thin films and they dissolve in the mouth. Oral transmucosal drugs can bypass hepatic first-pass metabolism and avoid degradation of drugs in the gastrointestinal tract.
MARKET HIGHLIGHTS
The Global Oral Transmucosal Drugs Market was valued at 28.65 billion USD in 2021 and is expected t%li%%li%reach 58.2 billion USD by 2032, increasing at a CAGR of 6.7% during the forecast period, i.e., 2022-2032 owing t%li%%li%increasing incidence of respiratory problems, autoimmune disorders, cancer, mucositis etc. The people getting affected by autoimmune disorders, respiratory problems, oral cancer, etc. are increasing leading t%li%%li%rise of the market across the world. This increases the requirement of oral transmucosal drugs t%li%%li%prevent gastrointestinal degradation and provide rapid onset of action. The number of patients with chronic diseases is rising across the world which increases the pre-surgical procedures which is expected t%li%%li%boost the global oral transmucosal drugs market.
Global Oral Transmucosal Drugs Market Segments
- By Product Type
- Tablets
- Films
- Liquid & Spray
- Others
- By Route of Administration
- Sublingual Mucosa
- Buccal Mucosa
- Others
- By Indication
- Opioid Dependence
- Nausea and Vomiting
- Erectile Dysfunction
- Neurological Disorders
- Others
- By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Growth Drivers
Incidence of chronic diseases may boost the market growth
Rising R&D activities may drive the market growth
Restraint
High Cost may restrain the market growth
Key Players
- ZIM Laboratories Limited
- Aquestive Therapeutics, Inc.
- IntelGenx Corp.
- C.L.Pharm Co., Ltd.
- Novartis AG
- Seoul Pharmaceuticals
- Pfizer Inc.
- Shilpa Therapeutics
- Teva Pharmaceutical Industries Ltd.
- Sunovion Pharmaceuticals, Inc.
- Other Prominent Players
Global Laboratory Temperature Control Units Market is further segmented by region into:
- North America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAG.R – United States and Canada
- Latin America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – Mexico, Argentina, Brazil and Rest of Latin America
- Europe Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – United Kingdom, France, Germany, Italy, Spain, Belgium, Hungary, Luxembourg, Netherlands, Poland, NORDIC, Russia, Turkey and Rest of Europe
- Asia Pacific Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – India, China, South Korea, Japan, Malaysia, Indonesia, New Zealand, Australia and Rest of APAC
- Middle East and Africa Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – North Africa, Israel, GCC, South Africa and Rest of MENA
- Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected t%li%%li%witness the fastest growth as well as t%li%%li%dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry with respect t%li%%li%recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis
- Provides insight int%li%%li%the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years t%li%%li%come
- 3-month post-sales analyst support.
1 EXECUTIVE SUMMARY
1.1. Regional Market Share
1.2. Business Trends
1.3. Global Oral Transmucosal Drugs Market: COVID-19 Outbreak
1.4. Regional Trends
1.5. Segmentation Snapshot
2 RESEARCH METHODOLOGY
2.1. Research Objective
2.2. Research Approach
2.3. Data Sourcing and Methodology
2.4. Primary Research
2.5. Secondary Research
2.5.1. Paid Sources
2.5.2. Public Sources
2.6. Market Size Estimation and Data Triangulation
3 MARKET CHARACTERISTICS
3.1. Market Definition
3.2. Global Oral Transmucosal Drugs Market: COVID-19 Impact
3.3. Key Segmentations
3.4. Key Developments
3.5. Allied Industry Data
4 GLOBAL ORAL TRANSMUCOSAL DRUGS MARKET – INDUSTRY INSIGHTS
4.1. Industry Segmentation
4.2. COVID-19 overview on world economy
4.3. Industry ecosystem Channel analysis
4.4. Innovation & Sustainability
5 MACROECONOMIC INDICATORS
6 RECENT DEVELOPMENTS
7 MARKET DYNAMICS
7.1. Introduction
7.2. Growth Drivers
7.3. Market Opportunities
7.4. Market Restraints
7.5. Market Trends
8 RISK ANALYSIS
9 MARKET ANALYSIS
9.1. Porters Five Forces
9.2. PEST Analysis
9.2.1. Political
9.2.2. Economic
9.2.3. Social
9.2.4. Technological
10 GLOBAL ORAL TRANSMUCOSAL DRUGS MARKET
10.1. Overview
10.2. Historical Analysis (2016-2021)
10.2.1. Market Size, Y-o-Y Growth (%) and Market Forecast
11 GLOBAL ORAL TRANSMUCOSAL DRUGS MARKET SIZE & FORECAST 2022A-2032F
11.1. Overview
11.2. Key Findings
11.3. Market Segmentation
11.3.1. By Product Type
11.3.1.1. Tablets
11.3.1.1.1. By Value (USD Million) 2022-2032F
11.3.1.1.2. Market Share (%) 2022-2032F
11.3.1.1.3. Y-o-Y Growth (%) 2022-2032F
11.3.1.2. Films
11.3.1.2.1. By Value (USD Million) 2022-2032F
11.3.1.2.2. Market Share (%) 2022-2032F
11.3.1.2.3. Y-o-Y Growth (%) 2022-2032F
11.3.1.3. Liquid & Spray
11.3.1.3.1. By Value (USD Million) 2022-2032F
11.3.1.3.2. Market Share (%) 2022-2032F
11.3.1.3.3. Y-o-Y Growth (%) 2022-2032F
11.3.1.4. Others
11.3.1.4.1. By Value (USD Million) 2022-2032F
11.3.1.4.2. Market Share (%) 2022-2032F
11.3.1.4.3. Y-o-Y Growth (%) 2022-2032F
11.3.2. By Route of Administration
11.3.2.1. Sublingual Mucosa
11.3.2.1.1. By Value (USD Million) 2022-2032F
11.3.2.1.2. Market Share (%) 2022-2032F
11.3.2.1.3. Y-o-Y Growth (%) 2022-2032F
11.3.2.2. Buccal Mucosa
11.3.2.2.1. By Value (USD Million) 2022-2032F
11.3.2.2.2. Market Share (%) 2022-2032F
11.3.2.2.3. Y-o-Y Growth (%) 2022-2032F
11.3.2.3. Others
11.3.2.3.1. By Value (USD Million) 2022-2032F
11.3.2.3.2. Market Share (%) 2022-2032F
11.3.2.3.3. Y-o-Y Growth (%) 2022-2032F
11.3.3. By Indication
11.3.3.1. Opioid Dependence
11.3.3.1.1. By Value (USD Million) 2022-2032F
11.3.3.1.2. Market Share (%) 2022-2032F
11.3.3.1.3. Y-o-Y Growth (%) 2022-2032F
11.3.3.2. Nausea and Vomiting
11.3.3.2.1. By Value (USD Million) 2022-2032F
11.3.3.2.2. Market Share (%) 2022-2032F
11.3.3.2.3. Y-o-Y Growth (%) 2022-2032F
11.3.3.3. Erectile Dysfunction
11.3.3.3.1. By Value (USD Million) 2022-2032F
11.3.3.3.2. Market Share (%) 2022-2032F
11.3.3.3.3. Y-o-Y Growth (%) 2022-2032F
11.3.3.4. Neurological Disorders
11.3.3.4.1. By Value (USD Million) 2022-2032F
11.3.3.4.2. Market Share (%) 2022-2032F
11.3.3.4.3. Y-o-Y Growth (%) 2022-2032F
11.3.3.5. Others
11.3.3.5.1. By Value (USD Million) 2022-2032F
11.3.3.5.2. Market Share (%) 2022-2032F
11.3.3.5.3. Y-o-Y Growth (%) 2022-2032F
11.3.4. By Distribution Channel
11.3.4.1. Hospital Pharmacies
11.3.4.1.1. By Value (USD Million) 2022-2032F
11.3.4.1.2. Market Share (%) 2022-2032F
11.3.4.1.3. Y-o-Y Growth (%) 2022-2032F
11.3.4.2. Retail Pharmacies
11.3.4.2.1. By Value (USD Million) 2022-2032F
11.3.4.2.2. Market Share (%) 2022-2032F
11.3.4.2.3. Y-o-Y Growth (%) 2022-2032F
11.3.4.3. Online Pharmacies
11.3.4.3.1. By Value (USD Million) 2022-2032F
11.3.4.3.2. Market Share (%) 2022-2032F
11.3.4.3.3. Y-o-Y Growth (%) 2022-2032F
12 NORTH AMERICA ORAL TRANSMUCOSAL DRUGS MARKET SIZE & FORECAST 2022A-2032F
12.1. Overview
12.2. Key Findings
12.3. Market Segmentation
12.3.1. By Product Type
12.3.2. By Route of Administration
12.3.3. By Indication
12.3.4. By Distribution Channel
12.4. Country
12.4.1. United States
12.4.2. Canada
13 EUROPE ORAL TRANSMUCOSAL DRUGS MARKET SIZE & FORECAST 2022A-2032F
13.1. Overview
13.2. Key Findings
13.3. Market Segmentation
13.3.1. By Product Type
13.3.2. By Route of Administration
13.3.3. By Indication
13.3.4. By Distribution Channel
13.4. Country
13.4.1. Germany
13.4.2. United Kingdom
13.4.3. France
13.4.4. Italy
13.4.5. Spain
13.4.6. Russia
13.4.7. Rest of Europe (BENELUX, NORDIC, Hungary, Turkey & Poland)
14 ASIA ORAL TRANSMUCOSAL DRUGS MARKET SIZE & FORECAST 2022A-2032F
14.1. Overview
14.2. Key Findings
14.3. Market Segmentation
14.3.1. By Product Type
14.3.2. By Route of Administration
14.3.3. By Indication
14.3.4. By Distribution Channel
14.4. By Country
14.4.1. India
14.4.2. China
14.4.3. South Korea
14.4.4. Japan
14.4.5. Rest of APAC
15 MIDDLE EAST AND AFRICA ORAL TRANSMUCOSAL DRUGS MARKET SIZE & FORECAST 2022A-2032F
15.1. Overview
15.2. Key Findings
15.3. Market Segmentation
15.3.1. By Product Type
15.3.2. By Route of Administration
15.3.3. By Indication
15.3.4. By Distribution Channel
15.4. Country
15.4.1. Israel
15.4.2. GCC
15.4.3. North Africa
15.4.4. South Africa
15.4.5. Rest of Middle East and Africa
16 LATIN AMERICA ORAL TRANSMUCOSAL DRUGS MARKET SIZE & FORECAST 2022A-2032F
16.1. Overview
16.2. Key Findings
16.3. Market Segmentation
16.3.1. By Product Type
16.3.2. By Route of Administration
16.3.3. By Indication
16.3.4. By Distribution Channel
16.4. Country
16.4.1. Mexico
16.4.2. Brazil
16.4.3. Rest of Latin America
17 COMPETITIVE LANDSCAPE
17.1. Company market share, 2021
17.2. Key player overview
17.3. Key stakeholders
18 COMPANY PROFILES
18.1. ZIM Laboratories Limited
18.1.1. Company Overview
18.1.2. Financial Overview
18.1.3. Key Product; Analysis
18.1.4. Company Assessment
18.1.4.1. Product Portfolio
18.1.4.2. Key Clients
18.1.4.3. Market Share
18.1.4.4. Recent News & Development (Last 3 Yrs.)
18.1.4.5. Executive Team
18.2. Aquestive Therapeutics, Inc.
18.3. IntelGenx Corp.
18.4. C.L.Pharm Co., Ltd.
18.5. Novartis AG
18.6. Seoul Pharmaceuticals
18.7. Pfizer Inc.
18.8. Shilpa Therapeutics
18.9. Teva Pharmaceutical Industries Ltd.
18.10. Sunovion Pharmaceuticals, Inc.
18.11. Other Prominent Players
19 APPENDIX
20 CONSULTANT RECOMMENDATION
1.1. Regional Market Share
1.2. Business Trends
1.3. Global Oral Transmucosal Drugs Market: COVID-19 Outbreak
1.4. Regional Trends
1.5. Segmentation Snapshot
2 RESEARCH METHODOLOGY
2.1. Research Objective
2.2. Research Approach
2.3. Data Sourcing and Methodology
2.4. Primary Research
2.5. Secondary Research
2.5.1. Paid Sources
2.5.2. Public Sources
2.6. Market Size Estimation and Data Triangulation
3 MARKET CHARACTERISTICS
3.1. Market Definition
3.2. Global Oral Transmucosal Drugs Market: COVID-19 Impact
3.3. Key Segmentations
3.4. Key Developments
3.5. Allied Industry Data
4 GLOBAL ORAL TRANSMUCOSAL DRUGS MARKET – INDUSTRY INSIGHTS
4.1. Industry Segmentation
4.2. COVID-19 overview on world economy
4.3. Industry ecosystem Channel analysis
4.4. Innovation & Sustainability
5 MACROECONOMIC INDICATORS
6 RECENT DEVELOPMENTS
7 MARKET DYNAMICS
7.1. Introduction
7.2. Growth Drivers
7.3. Market Opportunities
7.4. Market Restraints
7.5. Market Trends
8 RISK ANALYSIS
9 MARKET ANALYSIS
9.1. Porters Five Forces
9.2. PEST Analysis
9.2.1. Political
9.2.2. Economic
9.2.3. Social
9.2.4. Technological
10 GLOBAL ORAL TRANSMUCOSAL DRUGS MARKET
10.1. Overview
10.2. Historical Analysis (2016-2021)
10.2.1. Market Size, Y-o-Y Growth (%) and Market Forecast
11 GLOBAL ORAL TRANSMUCOSAL DRUGS MARKET SIZE & FORECAST 2022A-2032F
11.1. Overview
11.2. Key Findings
11.3. Market Segmentation
11.3.1. By Product Type
11.3.1.1. Tablets
11.3.1.1.1. By Value (USD Million) 2022-2032F
11.3.1.1.2. Market Share (%) 2022-2032F
11.3.1.1.3. Y-o-Y Growth (%) 2022-2032F
11.3.1.2. Films
11.3.1.2.1. By Value (USD Million) 2022-2032F
11.3.1.2.2. Market Share (%) 2022-2032F
11.3.1.2.3. Y-o-Y Growth (%) 2022-2032F
11.3.1.3. Liquid & Spray
11.3.1.3.1. By Value (USD Million) 2022-2032F
11.3.1.3.2. Market Share (%) 2022-2032F
11.3.1.3.3. Y-o-Y Growth (%) 2022-2032F
11.3.1.4. Others
11.3.1.4.1. By Value (USD Million) 2022-2032F
11.3.1.4.2. Market Share (%) 2022-2032F
11.3.1.4.3. Y-o-Y Growth (%) 2022-2032F
11.3.2. By Route of Administration
11.3.2.1. Sublingual Mucosa
11.3.2.1.1. By Value (USD Million) 2022-2032F
11.3.2.1.2. Market Share (%) 2022-2032F
11.3.2.1.3. Y-o-Y Growth (%) 2022-2032F
11.3.2.2. Buccal Mucosa
11.3.2.2.1. By Value (USD Million) 2022-2032F
11.3.2.2.2. Market Share (%) 2022-2032F
11.3.2.2.3. Y-o-Y Growth (%) 2022-2032F
11.3.2.3. Others
11.3.2.3.1. By Value (USD Million) 2022-2032F
11.3.2.3.2. Market Share (%) 2022-2032F
11.3.2.3.3. Y-o-Y Growth (%) 2022-2032F
11.3.3. By Indication
11.3.3.1. Opioid Dependence
11.3.3.1.1. By Value (USD Million) 2022-2032F
11.3.3.1.2. Market Share (%) 2022-2032F
11.3.3.1.3. Y-o-Y Growth (%) 2022-2032F
11.3.3.2. Nausea and Vomiting
11.3.3.2.1. By Value (USD Million) 2022-2032F
11.3.3.2.2. Market Share (%) 2022-2032F
11.3.3.2.3. Y-o-Y Growth (%) 2022-2032F
11.3.3.3. Erectile Dysfunction
11.3.3.3.1. By Value (USD Million) 2022-2032F
11.3.3.3.2. Market Share (%) 2022-2032F
11.3.3.3.3. Y-o-Y Growth (%) 2022-2032F
11.3.3.4. Neurological Disorders
11.3.3.4.1. By Value (USD Million) 2022-2032F
11.3.3.4.2. Market Share (%) 2022-2032F
11.3.3.4.3. Y-o-Y Growth (%) 2022-2032F
11.3.3.5. Others
11.3.3.5.1. By Value (USD Million) 2022-2032F
11.3.3.5.2. Market Share (%) 2022-2032F
11.3.3.5.3. Y-o-Y Growth (%) 2022-2032F
11.3.4. By Distribution Channel
11.3.4.1. Hospital Pharmacies
11.3.4.1.1. By Value (USD Million) 2022-2032F
11.3.4.1.2. Market Share (%) 2022-2032F
11.3.4.1.3. Y-o-Y Growth (%) 2022-2032F
11.3.4.2. Retail Pharmacies
11.3.4.2.1. By Value (USD Million) 2022-2032F
11.3.4.2.2. Market Share (%) 2022-2032F
11.3.4.2.3. Y-o-Y Growth (%) 2022-2032F
11.3.4.3. Online Pharmacies
11.3.4.3.1. By Value (USD Million) 2022-2032F
11.3.4.3.2. Market Share (%) 2022-2032F
11.3.4.3.3. Y-o-Y Growth (%) 2022-2032F
12 NORTH AMERICA ORAL TRANSMUCOSAL DRUGS MARKET SIZE & FORECAST 2022A-2032F
12.1. Overview
12.2. Key Findings
12.3. Market Segmentation
12.3.1. By Product Type
12.3.2. By Route of Administration
12.3.3. By Indication
12.3.4. By Distribution Channel
12.4. Country
12.4.1. United States
12.4.2. Canada
13 EUROPE ORAL TRANSMUCOSAL DRUGS MARKET SIZE & FORECAST 2022A-2032F
13.1. Overview
13.2. Key Findings
13.3. Market Segmentation
13.3.1. By Product Type
13.3.2. By Route of Administration
13.3.3. By Indication
13.3.4. By Distribution Channel
13.4. Country
13.4.1. Germany
13.4.2. United Kingdom
13.4.3. France
13.4.4. Italy
13.4.5. Spain
13.4.6. Russia
13.4.7. Rest of Europe (BENELUX, NORDIC, Hungary, Turkey & Poland)
14 ASIA ORAL TRANSMUCOSAL DRUGS MARKET SIZE & FORECAST 2022A-2032F
14.1. Overview
14.2. Key Findings
14.3. Market Segmentation
14.3.1. By Product Type
14.3.2. By Route of Administration
14.3.3. By Indication
14.3.4. By Distribution Channel
14.4. By Country
14.4.1. India
14.4.2. China
14.4.3. South Korea
14.4.4. Japan
14.4.5. Rest of APAC
15 MIDDLE EAST AND AFRICA ORAL TRANSMUCOSAL DRUGS MARKET SIZE & FORECAST 2022A-2032F
15.1. Overview
15.2. Key Findings
15.3. Market Segmentation
15.3.1. By Product Type
15.3.2. By Route of Administration
15.3.3. By Indication
15.3.4. By Distribution Channel
15.4. Country
15.4.1. Israel
15.4.2. GCC
15.4.3. North Africa
15.4.4. South Africa
15.4.5. Rest of Middle East and Africa
16 LATIN AMERICA ORAL TRANSMUCOSAL DRUGS MARKET SIZE & FORECAST 2022A-2032F
16.1. Overview
16.2. Key Findings
16.3. Market Segmentation
16.3.1. By Product Type
16.3.2. By Route of Administration
16.3.3. By Indication
16.3.4. By Distribution Channel
16.4. Country
16.4.1. Mexico
16.4.2. Brazil
16.4.3. Rest of Latin America
17 COMPETITIVE LANDSCAPE
17.1. Company market share, 2021
17.2. Key player overview
17.3. Key stakeholders
18 COMPANY PROFILES
18.1. ZIM Laboratories Limited
18.1.1. Company Overview
18.1.2. Financial Overview
18.1.3. Key Product; Analysis
18.1.4. Company Assessment
18.1.4.1. Product Portfolio
18.1.4.2. Key Clients
18.1.4.3. Market Share
18.1.4.4. Recent News & Development (Last 3 Yrs.)
18.1.4.5. Executive Team
18.2. Aquestive Therapeutics, Inc.
18.3. IntelGenx Corp.
18.4. C.L.Pharm Co., Ltd.
18.5. Novartis AG
18.6. Seoul Pharmaceuticals
18.7. Pfizer Inc.
18.8. Shilpa Therapeutics
18.9. Teva Pharmaceutical Industries Ltd.
18.10. Sunovion Pharmaceuticals, Inc.
18.11. Other Prominent Players
19 APPENDIX
20 CONSULTANT RECOMMENDATION
